Clinical Trial

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

Name: Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib — clinical trial record (NCT06855498)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: STOP-LTR

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

Rollover study for participants from predetermined, Incyte-sponsored parent clinical trials of povorcitinib.

Protocol Amendment History 2 changes

notable Trial sites reduced: 327 -> 316 locations 2026-04-09

notable Trial sites reduced: 330 -> 327 locations 2026-04-07

Trial Details

NCT Number	NCT06855498
Lead Sponsor	Incyte Corporation
Conditions	Hidradenitis Suppurativa (HS)
Enrollment	600 participants
Start Date	2025-02-28
Primary Completion	2028-02-28 (estimated)
Study Completion	2028-02-28 (estimated)
Updated on ClinicalTrials.gov	2026-08-06